Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2025-05-22 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
2024年年度股东大会法律意见
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the 2024 Annual General Meeting (AGM) of a company. It details the procedures of the AGM, the qualifications of attendees, the voting process, and the results of various resolutions including approval of the 2024 annual report, financial statements, profit distribution, and other corporate matters. The document is dated May 22, 2025, and is focused on the AGM event and its legal compliance. It does not contain the actual annual report or financial statements but rather the legal opinion on the AGM and voting results. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting outcomes of the AGM resolutions.
2025-05-22 Chinese
2024年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2024 年年度股东大会决议公告" which translates to "2024 Annual General Meeting Resolution Announcement." It details the resolutions passed at the 2024 Annual General Meeting (AGM) of the company, including voting results on various proposals such as the annual report, board work report, financial statements, profit distribution, and other governance matters. The document includes attendance details, voting percentages, and legal opinions on the meeting's validity. It does not contain the full annual report or financial statements themselves but reports on the AGM decisions and voting outcomes. The document length is 4681 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-05-22 Chinese
关于聘任高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement from a company regarding the appointment of a senior management personnel, specifically the appointment of Mr. Xiao Lin as Vice General Manager. It includes details about the appointment, the approval process by the board, and the resume of the appointed individual. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to shareholder votes or meetings. The content clearly fits the category of announcements related to changes in senior management. Therefore, the document is best classified as Board/Management Information (MANG). The document length is short and focused solely on management appointment, confirming this classification with high confidence.
2025-05-16 Chinese
第五届董事会第七次会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of the resolutions passed at the seventh meeting of the fifth board of directors of a company. It details the appointment of a senior management person (vice general manager), the meeting date, voting results, and references to related committee meetings. It does not contain financial statements or detailed financial data. It is a formal announcement about board decisions, specifically about management appointments. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report or presentation but an official announcement of board decisions.
2025-05-16 Chinese
关于使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about the progress of using idle funds for cash management, including specifics of financial products purchased, risk control measures, and impact on the company. It is not a full financial report like an Annual Report or Interim Report, nor is it a brief earnings release or a call transcript. It is a regulatory announcement about financing activities related to cash management and investment of idle funds. The document length is 7347 characters, which is substantive but the content is focused on capital management and investment updates rather than comprehensive financial statements or management discussion. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2025-05-09 Chinese
关于双醋瑞因胶囊获得上市许可受理的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company about receiving a regulatory acceptance notice for a drug registration application from the National Medical Products Administration (国家药品监督管理局). It details the drug name, application number, and the regulatory process status. The document is short (775 characters) and serves as an announcement of a regulatory event rather than a financial report or detailed filing. It does not contain financial data, management changes, voting results, or other report types. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-05-08 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.